Julie Beal

Julie Beal serves as Co-Owner & CEO at Zigzag Associates Ltd. Zigzag Associates Ltd operates in the pharmaceuticals sector with approximately 52.0 employees. The company is headquartered in Oxford, England. Zigzag Associates Ltd generates annual revenue of 4000000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 2,805 owner-level executives.

Salesforce Outlook Microsoft Office 365 Google Cloud Hosting Pardot Varnish Google Analytics Google Tag Manager Adobe Media Optimizer Mobile Friendly Cedexis Radar Vimeo Wix Remote

quality assurance auditing gcp gvp gmp glp gclp gdp pharmacovigilance gxp training inspection support qms support computer system validation artificial intelligence compliance pharmaceutical manufacturing qa services gxp auditing good clinical practice gcp good pharmacovigilance practice good manufacturing practice good distribution practice good laboratory practice good clinical laboratory practice computerized system validation csv pharmaceutical auditing biotech compliance medical device quality clinical research qa auditing services regulatory compliance clinical trials risk management auditor training pharmacovigilance guidelines regulatory inspection qa processes audit report writing quality management systems capable guidance global reach customized qa programs therapeutic areas remote audits on-site audits inspection readiness adaptability in auditing comprehensive qa solutions project management in qa audit flexibility quality control standards continuous improvement pharmaceutical quality assurance clinical quality management data management in trials training in gcp biotech quality control quality assurance experts pharmaceutical industry biotechnology medical devices gxp audits inspection preparation tailored services global presence women-owned business client collaboration training & consultancy iso standards quality culture healthcare compliance tailored qa programs expert guidance operational efficiency quality outcomes client support diverse clientele international trade quality improvement comprehensive qa services pharmaceuticals medical health care health wellness & fitness hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Julie Beal in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Zigzag Associates Ltd.

How do I reach Julie Beal directly?

Julie Beal's verified email address is available to MessageCEO Pro subscribers. They currently serve as Co-Owner & CEO at Zigzag Associates Ltd. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Julie Beal work for?

Julie Beal is Co-Owner & CEO at Zigzag Associates Ltd, a company in the pharmaceuticals sector with 52.0 employees. The company is based in Oxford, England.

Can I pitch or sell to Julie Beal?

As Co-Owner & CEO at Zigzag Associates Ltd, Julie Beal is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Julie Beal directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Julie Beal in?

Julie Beal works in the pharmaceuticals industry as Co-Owner & CEO at Zigzag Associates Ltd. MessageCEO provides verified contact information for executives across all major industries.

Is Julie Beal's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Julie Beal's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026